Alloy Vs Midi Health

Alloy and Midi Health are both virtual menopause clinics, and both will prescribe FDA-approved hormone therapy without an in-person appointment. That is where the similarity stops. Alloy charges $49 once, never sees you live, and sells the medication itself at a published monthly price. Midi Health bills your insurance for a real 30-minute clinical visit, may order labs, and sends the prescription to your own pharmacy.

The practical result is that each platform is cheap in the half of the bill the other one is expensive in. Comparing their headline prices tells you almost nothing. Comparing what a full year of treatment costs, and what gets measured along the way, tells you everything.

What each platform actually is

Alloy

Alloy is an asynchronous prescribing service with its own pharmacy attached. You complete a short assessment, a doctor reviews it, and a plan comes back through a secure portal. Alloy states that its consult doctors have been certified by The Menopause Society for over 10 years, and that the assessment takes about three minutes with a plan returned in under 12 hours. The consult fee is $49, charged once, with no membership or subscription behind it.

Medication is where the model earns its money, and Alloy publishes every price. Estradiol comes as a pill at $39.99 a month, a gel at $69.99, the Evamist spray at $69.99, or a patch at $100. Progesterone starts at $23 a month, paroxetine is $34.99, and estradiol vaginal cream is $119.97 for a three-month supply. Delivery is free, insurance is not accepted, and HSA and FSA funds are. Buying a prescription unlocks unlimited messaging with the prescribing doctor. There is no lab panel in the standard path, and no scheduled retest.

Midi Health

Midi Health is a virtual clinical practice that bills insurance. It states it is in-network with most PPO plans, naming Aetna, Blue Cross Blue Shield, Cigna, Health Net and UnitedHealthcare, and that it operates in all 50 states. Medicare is out of network, and Medicaid and Medi-Cal patients are not accepted. Self-pay pricing is published: $250 for a first visit and $150 for a returning visit, with HSA and FSA accepted and no subscription fee.

The first visit runs 30 minutes and the follow-ups run 15. Clinicians are board-certified nurse practitioners, certified nurse midwives, physicians and naturopathic doctors specializing in midlife women's health, and several hold Menopause Society certification. Midi states its protocols draw on guidance from ACOG, the AMA, ISSWSH, The Menopause Society, the NCCN and The Obesity Association. Labs may be ordered when indicated, including a metabolic panel, thyroid testing and insulin-sensitivity markers, generally through Labcorp, and billed separately. Prescriptions go to your pharmacy; some products are available after a shorter asynchronous visit rather than a full one.

Side by side on the standard rubric

Ten criteria, applied identically to both columns. Everything below the table explains where those cells come from.

What each actually costs

Alloy's structure is unusually easy to total. The consult is $49 and it does not repeat. Medication carries a published price that does not change with your insurance status, your state, or your deductible. A woman on the estradiol patch plus progesterone can calculate her year before she starts: $49 plus twelve months at $100 plus twelve months from $23, which lands near $1,525. On the pill instead of the patch, the same year is roughly $805. Nothing is metered per message and nothing is billed for labs, because there are no labs.

Midi Health cannot be totaled the same way, and that is a function of billing insurance rather than a lack of transparency. The visit price is published for self-pay at $250 and $150, so a year with two follow-ups costs $550 in visits. Insured, the visit cost is whatever your plan applies, which can be a small copay or the full contracted rate against an unmet deductible. The medication then sits on your pharmacy benefit, where a generic transdermal estradiol patch commonly runs a fraction of Alloy's $100 monthly price, and sometimes more if the plan excludes it. Labs add their own line.

Four common scenarios, priced

Where Alloy leads

• Total cost is knowable in advance. Every product price is published, the consult is a single $49 charge, and delivery is free, so a full year can be calculated before any money is spent.
• No insurance friction. There is no benefit check, no network question, no prior authorization and no deductible, which makes it usable by uninsured women and by anyone whose plan excludes menopause care.
• Speed to a plan. The assessment takes about three minutes and Alloy states a plan comes back in under 12 hours, with no appointment to schedule and no waiting room.
• Menopause-specific prescribers. Alloy states its consult doctors have held Menopause Society certification for over 10 years, so the clinician reading the assessment is a specialist rather than a generalist.
• Unlimited messaging after purchase. Follow-up questions do not generate a new charge or a new appointment once a prescription is in place.

Where Midi Health leads

• Insurance actually pays. In-network status with most PPO plans, including Aetna, Blue Cross Blue Shield, Cigna, Health Net and UnitedHealthcare, moves the visit cost onto the plan rather than onto you.
• Labs are part of the picture. A metabolic panel, thyroid testing and insulin-sensitivity markers can be ordered when indicated, so a non-hormonal cause of the symptoms can surface instead of being assumed away.
• A real clinical visit. Thirty minutes with a clinician, and 15-minute follow-ups afterward, allow a history to be taken and contraindications to be discussed in conversation.
• Broader clinician mix. Nurse practitioners, nurse midwives, physicians and naturopathic doctors are represented, several with Menopause Society certification, and stated protocols draw on ACOG, ISSWSH, NCCN and Menopause Society guidance.
• Nationwide and pharmacy-agnostic. Availability in all 50 states, and prescriptions written to the pharmacy of your choice rather than filled in-house.

Trade-offs to weigh

Alloy trade-offs

• The flat price can be the higher price. $100 a month for an estradiol patch is a ceiling, not a discount, and a covered generic on a decent pharmacy benefit frequently costs less.
• Nothing gets measured. No panel means no thyroid, ferritin, fasting insulin or ApoB result, at the exact life stage those values move most.
• No live conversation in the standard path. A written assessment carries less nuance than a history taken out loud, particularly around bleeding patterns and family history.
• State availability is not universal. Alloy states the service may not be available in every state, so confirm yours before paying the consult fee.

Midi Health trade-offs

• Your cost is unknowable up front. Insured pricing depends on deductible, coinsurance and copay, so the same visit costs different women very different amounts.
• Coverage gaps are real. Medicare is out of network, Medicaid and Medi-Cal are not accepted, and non-PPO plans may not be in-network at all.
• Labs and drugs are separate bills. Midi notes additional cost may apply for labs and prescriptions, which arrive after the visit rather than with it.
• Two civil suits are pending. N.C. v. Midi Health, Inc. (No. 5:25-cv-02848) and Baker v. Midi Health, Inc. (No. 5:25-cv-10414) are both undecided in the Northern District of California, and allegations are not findings. Midi's published terms also include an arbitration clause and class-action waiver.

Who should pick each

Pick Alloy if: the hormone decision is already made, you want the year priced before you commit, and no insurance is going to help you. You are comfortable with a written assessment instead of a conversation, your thyroid and iron picture is already known and stable, and a predictable monthly medication charge is worth more to you than a variable one that might be lower.

Pick Midi Health if: you carry a PPO plan, or your symptoms are not clearly explained yet. Fatigue, weight change and brain fog at this age overlap almost completely with thyroid disease and iron deficiency, and the clinician who can order those tests is the one who should be weighing hormones. You accept that the total will only be knowable after the claims process, in exchange for having the underlying questions answered.

Who should pick neither

Both platforms are built for a woman who can be prescribed for remotely. Several situations do not fit that shape, and starting either one delays the care that would help.

• Unscheduled or heavy bleeding. Bleeding that is new, heavy or postmenopausal needs evaluation, not a prescription adjusted around it. That means an in-person gynecologic workup.
• A history that complicates systemic estrogen. Breast or estrogen-sensitive cancer, prior clot or stroke, active liver disease or known thrombophilia belong in a conversation with a clinician holding your full record. Our HRT side effects and risks page covers the absolute numbers behind those cautions.
• You want the full picture measured first. A dedicated panel reads hormones alongside thyroid, ferritin, fasting insulin and ApoB. See the perimenopause biomarker panel for what belongs on it and when to draw each marker.
• You have not decided whether hormones are the answer. Non-hormonal options exist and have trial support. The hormone therapy platforms comparison lays out both routes on one rubric.

What the rubric does not capture

The table shows who prescribes and what it costs. It does not show what happens to a question that has no answer yet. Alloy's standard path includes no lab order, so a thyroid signal in the assessment cannot be tested on that path. Midi's clinicians can order that panel, and the result can change the diagnosis. Neither structure is wrong for what each platform sells, but the two produce different information from identical symptoms.

Commitment shape differs too. At Alloy there is no subscription to cancel and no visit to schedule, so the cost of being wrong about the platform is $49 plus whatever medication you already bought. Midi charges nothing between visits either, and its per-visit billing means you commit to one appointment at a time, though an insurance claim can arrive weeks later, so the amount is not visible at the moment you decide. Neither structure is wrong; they make the cost legible at different times.

One more point sits outside both companies' control. Menopause care is priced in two places, the clinician and the pharmacy, and these two platforms have each optimized a different one. Any woman with a functioning pharmacy benefit is comparing a $100 published patch price against a copay she has never looked up. Any woman without one is comparing a knowable $1,525 year against a claims process. The right answer changes with a single phone call to a pharmacist, and it is the call almost nobody makes before signing up.

Related

• Full Alloy review
• Full Midi Health review
• Alloy cost breakdown
• Midi Health cost breakdown
• Hormone therapy platforms compared on one rubric
• All doctor-led options compared